TY - JOUR
KW - Adult
KW - buprenorphine-naloxone
KW - Buprenorphine/therapeutic use
KW - Chronic Pain
KW - Chronic Pain/physiopathology
KW - Drug Therapy, Combination
KW - Female
KW - Humans
KW - Male
KW - multilevel modeling
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/drug therapy
KW - Prediction
KW - prescription opiates
KW - Severity of Illness Index
KW - Treatment Outcome
KW - Treatment Outcomes
KW - United States
AU - M. J. Worley
AU - K. G. Heinzerling
AU - S. Shoptaw
AU - W. Ling
A1 - 
BT - Addiction (Abingdon, England)
C5 - Opioids & Substance Use
CP - 7
CY - England
DO - 10.1111/add.13782
IS - 7
JF - Addiction (Abingdon, England)
PB - Society for the Study of Addiction
PP - England
PY - 2017
SN - 1360-0443; 0965-2140
SP - 1202
EP - 1209
EP - 
T1 - Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction
T2 - Addiction (Abingdon, England)
TI - Volatility and change in chronic pain severity predict outcomes of treatment for prescription opioid addiction
U1 - Opioids & Substance Use
U2 - 28164407
U3 - 10.1111/add.13782
VL - 112
VO - 1360-0443; 0965-2140
Y1 - 2017
ER -